aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.4404
-0.0350 (-7.36%)
At close: Jun 12, 2026, 4:00 PM EDT
0.4418
+0.0014 (0.32%)
After-hours: Jun 12, 2026, 7:53 PM EDT
aTyr Pharma Employees
As of December 31, 2025, aTyr Pharma had 60 total employees, including 58 full-time and 2 part-time employees. The number of employees increased by 1 or 1.69% compared to the previous year.
Employees
60
Change (1Y)
1
Growth (1Y)
1.69%
Revenue / Employee
$3,167
Profits / Employee
-$1,167,150
Market Cap
43.18M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 60 | 1 | 1.69% | 58 | 2 |
| Dec 31, 2024 | 59 | 0 | - | 56 | 3 |
| Dec 31, 2023 | 59 | -11 | -15.71% | 56 | 3 |
| Dec 31, 2022 | 70 | 17 | 32.08% | 65 | 5 |
| Dec 31, 2021 | 53 | 10 | 23.26% | 49 | 4 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Metagenomi Therapeutics | 119 |
| Xilio Therapeutics | 76 |
| Mereo BioPharma Group | 39 |
| Tevogen Bio Holdings | 18 |
| Actuate Therapeutics | 12 |
| Genenta Science | 9 |
| KALA BIO | 6 |
ATYR News
- 10 days ago - aTyr Pharma Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 19 days ago - Forget the SpaceX IPO. These 2 New Stocks Stand Out Right Now. - Barrons
- 24 days ago - Ethos Partners with Baseball Legend David Ortiz to Champion Life Insurance as a Family Financial Essential - GlobeNewsWire
- 25 days ago - aTyr Pharma upgraded to Buy from Hold at Freedom Broker - TheFly
- 4 weeks ago - Ethos to Present at Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - aTyr Pharma reports Q1 EPS (11c), consensus (15c) - TheFly
- 4 weeks ago - aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update - GlobeNewsWire
- 4 weeks ago - aTyr Pharma Quarterly report: Q1 2026 - Filings